3304-module 1-
TRANSCRIPT
-
8/8/2019 3304-Module 1-
1/84
NURS 3304PHARMACOTHERAPEUTICS
Adrianne Linton PhD RN
Jennie Shaw MSN RN
Blackboard Assistance byMaryShannon Williams
-
8/8/2019 3304-Module 1-
2/84
Course Objectives
CourseObjectives
-
8/8/2019 3304-Module 1-
3/84
Examinetheroleofdrugtherapyinrelationtohealthpromotion, diseasepreventionand managementacrossthelifespan. (Essential VII, IX)
Incorporateunderstandingofdrug
classificationsand actions. (Essential VII,IX)
Identifyrelevantassessment data,
appropriatenursinggoalsandintervention,and evaluation datarelatedto drugtherapy. (Essential IX)
-
8/8/2019 3304-Module 1-
4/84
Identifytheneed forcustomizationofdrug
therapy based onindividualpatientvariablesincludingphysiologic,psychosocial,genetic,cultural,patientbeliefsystem, knowledge baseandresources. (Essential VII, IX)
Integrate knowledgeofphysicalandbehavioralscienceswithlegaland ethical
guidelinestoplanforsafeand effectiveimplementationofpharmacotherapeutics.(Essential I, II, V, IX)
-
8/8/2019 3304-Module 1-
5/84
Identifystrategiestoemployintraprofessionalcommunicationrelated to
patients drugtherapy. (Essential VI, IX)Describehowthenursepreparespatientsand theirfamiliestomanageself-pharmacotherapeutics. (Essential VI, IX)
-
8/8/2019 3304-Module 1-
6/84
Identifyinformationtechnologysourcesfortheacquisitionand applicationofevidence-based guidelinestopractice.
(Essential III. IV, IX)
Usecriticalthinkingprocesstoapplyknowledgeofpharmacologytoplansafe
and effective drugtherapy. (Essential I, IX)
-
8/8/2019 3304-Module 1-
7/84
DrugCalculations.
The SchoolofNursinghasadoptedDimensional Analysisasthemethod of
performingmath/
drug
calculations.
Itisexpected thatyoualready know basicmathand youwillhaveanopportunitytoreviewthisskill.
-
8/8/2019 3304-Module 1-
8/84
Criteria for Evaluation
Grade Percentages:
25%- Exam 125%- Exam230%- FinalExam10%- CurrentEvent Written Assignment10%- Blackboard Activitiesand
Participation100% - Total
-
8/8/2019 3304-Module 1-
9/84
TextbooksRequired Lehne, R. A. (2010) Pharmacology for Nursing Care
(7thed.)
Mulholland, JoyceM. (2007) The Nurse, The Math,The Meds: Drug Calculations using Dimensional
Analysis
Recommended
Basch & Ulbright:Natural Standard Herb andSupplement Handbook(2005)
Publication Manual of the American PsychologicalAssociation (2009)
-
8/8/2019 3304-Module 1-
10/84
Equivalencies
1 liter (L) = 1000 milliliters
(mL)
1 kilogram (kg) = 1000 grams 1 gram (g) = 1000 milligrams
(mg)
1 milligram (mg) = 1000micrograms (mcg)
-
8/8/2019 3304-Module 1-
11/84
Equivalencies 1 tsp = 5 mL
1 Tbsp = 15 mL
1 ounce = 30 mL
1 glass = 240 mL
1 gr = 60, 64, or 65
mg
15 gr = 1 Gm 1 kg = 2.2 lbs
-
8/8/2019 3304-Module 1-
12/84
Abbreviations
cc oz IV
g,gm, Gm ss OD
gr T.O. OS
gtt Unit OU
kg V.O. PO
L,l x (times) PR
mcg, g < SC,subc,scmEq > Sl,sl
Mg,mg ID Vag
ml IM
-
8/8/2019 3304-Module 1-
13/84
AbbreviationsAC PC STAT
Ad lib PRN TID
c Q,q
H,h Q AM
hs,HS QIDNPO s
-
8/8/2019 3304-Module 1-
14/84
Do Not Use Abbreviations
The JointCommission
http://www.jointcommission.org
Patient SafetyDo Not Use List
National Patient Safety Goals
-
8/8/2019 3304-Module 1-
15/84
PharmacologyPharmacology
A sciencethat drawsoninformationfromA sciencethat drawsoninformationfrommultiple disciplines,including:multiple disciplines,including:AnatomyAnatomyPhysiologyPhysiologyPsychologyPsychologyChemistryChemistry
MicrobiologyMicrobiology
-
8/8/2019 3304-Module 1-
16/84
-
8/8/2019 3304-Module 1-
17/84
BasicTermsBasicTerms
ClinicalpharmacologyClinicalpharmacologyStudyofdrugsinhumansStudyofdrugsinhumans
TherapeuticsTherapeutics
Theuseofdrugsto diagnose,prevent,Theuseofdrugsto diagnose,prevent,ortreat diseaseortopreventortreat diseaseortopreventpregnancy,ormoresimply: themedicalpregnancy,ormoresimply: themedical
useofdrugsuseofdrugs
-
8/8/2019 3304-Module 1-
18/84
Conventional Drugs
Used in Westernmedicine
Productionregulated
Meetstandardsforsafetyand efficacy Includeprescriptionand OTCs
-
8/8/2019 3304-Module 1-
19/84
Non-allopathic Agents Folk remedies
Herbalsupplements
Limited evidenceofsafetyandefficacy (butgrowing)
Promoteconsumerchoiceand
selftreatment
-
8/8/2019 3304-Module 1-
20/84
USES OF DRUG THERAPYDrugs modify existing functions on a tissue orbody organ
Drugs do not create new functions important to
know this.
Restorenormallevelofdeficientsubstances
Block harmfulphysiologicprocesses
Stimulatehealthyphysiologicprocesses
-
8/8/2019 3304-Module 1-
21/84
USES (cont.)
Destroypathogens
Destroyabnormaltissue
Protectvulnerabletissue-sunscreenex,creams
toprotecttheskin Eliminateexcessorharmfulsubstances-
direutics,
Reducesymptoms-exTylenol.
-
8/8/2019 3304-Module 1-
22/84
FUNDAMENTAL PRINCIPLES
All drugs are potential poisons when
taken in sufficiently high doses
No drug produces one, and only one,effect
-
8/8/2019 3304-Module 1-
23/84
Orientationto PharmacologyOrientationto Pharmacology
Propertiesofanideal drugThetherapeuticobjectiveFactorsthat determinetheintensityof
drugresponsesTherapeutics
-
8/8/2019 3304-Module 1-
24/84
ThreeMost ImportantThreeMost ImportantPropertiesofan Ideal DrugPropertiesofan Ideal Drug
1.1.EffectivenessEffectiveness--doeswhatissupposeto dodoeswhatissupposeto do2.2. SafetySafety--thereisnosuchthingasasafethereisnosuchthingasasafe
drugdrug3.3. SelectivitySelectivity--meaningthatit doesnt ONLYmeaningthatit doesnt ONLY
whatitsmeantto do,BUT NO SUCHwhatitsmeantto do,BUT NO SUCHDRUG EXISTS.DRUG EXISTS.
-
8/8/2019 3304-Module 1-
25/84
Additional Propertiesofan Ideal DrugAdditional Propertiesofan Ideal Drug
Reversibleaction-ex. Anethesia,morphinePredictability-cant betotallypredicted,
everyoneis different.Easeofadministration-expill,insulin by
injection,Freedomfrom druginteractions-
Lowcost-Chemicalstability-Simplegenericname-
But becauseno drugisideal
-
8/8/2019 3304-Module 1-
26/84
Therapeutic ObjectiveofTherapeutic ObjectiveofDrugTherapyDrugTherapy
Providemaximum benefitwithProvidemaximum benefitwithminimumharmminimumharm
-
8/8/2019 3304-Module 1-
27/84
FactorsThat Determinethe IntensityofFactorsThat Determinethe IntensityofDrug ResponsesDrug Responses
AdministrationAdministration--PharmacokineticsPharmacokinetics--how drugsmovehow drugsmove
throughyourbodythroughyourbodyPharmacodynamicsPharmacodynamics--how dotheyworkhow dotheyworkSourcesofindividualvariationSourcesofindividualvariation
-
8/8/2019 3304-Module 1-
28/84
Fig. 1-1.The four basic pharmacokinetic processes.Dotted linesrepresentmembranesthatmust becrossed as drugsmovethroughoutthe body.
-
8/8/2019 3304-Module 1-
29/84
AdministrationAdministration
Important determinantsofdrugresponses:Important determinantsofdrugresponses:dosagesize,route,timingdosagesize,route,timing
MedicationerrorsMedicationerrorsPatientadherencePatientadherence
-
8/8/2019 3304-Module 1-
30/84
PharmacokineticsPharmacokinetics
DetermininghowmuchofadministeredDetermininghowmuchofadministereddosegetstoitssitesofactiondosegetstoitssitesofaction
Impactofthe bodyon drugsImpactofthe bodyon drugsFourmajorpharmacokineticprocesses:Fourmajorpharmacokineticprocesses:DrugabsorptionDrugabsorptionDrug distributionDrug distributionDrugmetabolismDrugmetabolismDrugexcretionDrugexcretion
-
8/8/2019 3304-Module 1-
31/84
PharmacodynamicsPharmacodynamics
Impactofdrugsonthe bodyImpactofdrugsonthe bodyDrugDrug--receptorinteractionreceptorinteractionBindingofthe drugtoitsreceptorBindingofthe drugtoitsreceptor
-
8/8/2019 3304-Module 1-
32/84
Sourcesof Individual VariationSourcesof Individual Variation
PhysiologicvariablesPhysiologicvariablesAge,gender,weightAge,gender,weight
PathologicvariablesPathologicvariablesDiminished functionofkidneysand liverDiminished functionofkidneysand liver
GeneticvariablesGeneticvariablesCanaltermetabolismofdrugsand predisposeCanaltermetabolismofdrugsand predisposepatienttouniqueinteractionspatienttouniqueinteractions
DruginteractionsDruginteractions
-
8/8/2019 3304-Module 1-
33/84
Key PointsKey Points
Thereisnosuchthingasasafe drug;allThereisnosuchthingasasafe drug;alldrugscancauseharm.drugscancauseharm.
Thereisnosuchthingasaselective drug;Thereisnosuchthingasaselective drug;all drugscancausesideeffects.all drugscancausesideeffects.
TheobjectiveofdrugtherapyistoprovideTheobjectiveofdrugtherapyistoprovidemaximum benefitwithminimumharm.maximum benefitwithminimumharm.
Becauseallpatientsareunique, drugBecauseallpatientsareunique, drugtherapymust betailored toeachtherapymust betailored toeachindividual.individual.
-
8/8/2019 3304-Module 1-
34/84
Chapter2Chapter2
ApplicationofPharmacologyinApplicationofPharmacologyinNursing PracticeNursing Practice
-
8/8/2019 3304-Module 1-
35/84
Nursing Responsibilities Regarding DrugsNursing Responsibilities Regarding Drugs
Thenursemust knowThenursemust knowWhatmedicationsareappropriateforWhatmedicationsareappropriatefor
thepatientthepatientWhat drugsarecontraindicated fortheWhat drugsarecontraindicated forthepatientpatient
TheprobableconsequencesoftheTheprobableconsequencesofthe
interaction between drugand patientinteraction between drugand patient
-
8/8/2019 3304-Module 1-
36/84
Nursing Responsibilities Regarding DrugsNursing Responsibilities Regarding Drugs
zz Correctadministration,withoutCorrectadministration,withoutadditionalinterventions,cannotensureadditionalinterventions,cannotensure
thattreatmentwillresultinthethattreatmentwillresultinthetherapeuticobjective.therapeuticobjective.--zz TherapeuticobjectiveistoprovideTherapeuticobjectiveistoprovidemaximum benefitwithminimalharm.maximum benefitwithminimalharm.
-
8/8/2019 3304-Module 1-
37/84
Nursing Responsibilities Regarding DrugsNursing Responsibilities Regarding Drugs
ThenursesroleasadvocateThenursesroleasadvocateFollowsthepatientsstatusmostcloselyFollowsthepatientsstatusmostcloselyFirstmemberofthehealthcareteamtoFirstmemberofthehealthcareteamto
observeand evaluate drugresponsesandobserveand evaluate drugresponsesandinterveneifrequiredinterveneifrequiredMust knowtheresponsethatamedicationisMust knowtheresponsethatamedicationis
likelytoelicitlikelytoelicit
LastlineofdefenseforthepatientLastlineofdefenseforthepatient--lastpersonlastpersonthepatientcancountonthepatientcancounton
-
8/8/2019 3304-Module 1-
38/84
Pharmacologyin PatientCare
Nurseresponsibilityand
accountability
Patienthasacardiacarrestafterreceivingarapid infusionofpotassium.-
-
8/8/2019 3304-Module 1-
39/84
Nurse Responsibilityand Accountability
Pregnantwomanhasapreservativeinstead
ofananesthetic druginjected intoherspinalcolumn. Sheistotallyparalyzed and
diesseveralmonthslater.
NICU babies die
afteroverdoseofheparin.
-
8/8/2019 3304-Module 1-
40/84
As a nurse you are responsible for
every drug that you administer.
-
8/8/2019 3304-Module 1-
41/84
The Nursing Processguidesthenurseinadministering drugssafely.
-
8/8/2019 3304-Module 1-
42/84
The Nursing Process
Assessment
Nursing Diagnosis
Planning/GoalsInterventions
Evaluation
-
8/8/2019 3304-Module 1-
43/84
Assessment: Patient- this always
happens FIRST
Currentstatus-levelofconscious
Past (health) history
Medicationhistory
Allergies
-
8/8/2019 3304-Module 1-
44/84
Assessment: Patient
Identifyinghigh-risk patientsLiverand kidneyimpairmentGeneticfactorsDrugallergiesPregnancyElderlyand pediatrics
Tools:patienthistory,physicalexam,and lab results
-
8/8/2019 3304-Module 1-
45/84
-
8/8/2019 3304-Module 1-
46/84
Assessment: Delivery systemDrugadministrationand security
Drughandling
Dosagemeasuring
Obtainingthe drug
Systemsused to dispensethe drug
Howto document drugtherapyontheMAR (medicationadministrationrecord)
-
8/8/2019 3304-Module 1-
47/84
Nursing DiagnosesAcute pain related totissue
traumaand reflexmusclespasms
secondarytosurgeryasevidencedbygrimacing,reluctancetogetoutofbed,and apainscoreof8.
Risk for injury related tosedatingeffectsofopioid analgesics
-
8/8/2019 3304-Module 1-
48/84
Planning/Setting Goals
Patientwillhavepainlevelof3 orlesswithin 30 minutesofadministrationofmorphine
Patientwillremainsafeafterpainmedicationisadministered asevidenced bynofallsorinjuriestoday
-
8/8/2019 3304-Module 1-
49/84
Interventions:Drug Administration
Six rights
Patient 2identifiers!
Drug
Dose
Route
Time
Right documentationrighttorefuse
Isthisenoughtomeetthe
therapeuticobjective?
-
8/8/2019 3304-Module 1-
50/84
Interventions:Drug Administration
Keepmedicationsecure-Be knowledgeableaboutinstitutionspoliciesand procedures
Neveradministermedicationprepared byanothernurse-
Nursemustobservepatienttaking
medication-
-
8/8/2019 3304-Module 1-
51/84
Interventions:Drug Administration
Certain drugshavemorethanoneindication. Dosagemay differdependingonwhichindicationthe drugisused for.
Many drugscan beadministered bymorethanoneroute. Dosagemay differdependingontherouteselected.
Certain IV agentscancauseseverelocalinjuryif IV extravasates.
-
8/8/2019 3304-Module 1-
52/84
Interventions:
DocumentationWhentochart-doitimmediatelyafteryougivemeds.
Wheretochart-
Whattochart
Whygivenornot (PRN vsroutine)
Effects
Otherrelevant data
-
8/8/2019 3304-Module 1-
53/84
-
8/8/2019 3304-Module 1-
54/84
Interventions:
Teaching
Considerations
KnowledgeReadinessto
learn
Environment
-
8/8/2019 3304-Module 1-
55/84
TeachingMay Include
Drug
Schedule
TherapeuticeffectsAdverseeffects
Interactions
Handling/storage
Effectsofsuddenlydiscontinuing
Whatifdosemissed
Safetyconsiderations
-
8/8/2019 3304-Module 1-
56/84
Evaluation
OfDrugEffects
Therapeuticresponse
Adverseeffect (includessideeffects)
Interactiveeffects
Furtherteachingneeds
-
8/8/2019 3304-Module 1-
57/84
PromotingTherapeuticEffectsPromotingTherapeuticEffects
PromotingpatientadherencePromotingpatientadherenceAlso knownascomplianceorconcordanceAlso knownascomplianceorconcordanceExtenttowhichapatients behaviorcoincidesExtenttowhichapatients behaviorcoincides
withmedicaladvicewithmedicaladvice ImplementingnondrugmeasuresImplementingnondrugmeasuresDrugtherapycanoften beenhanced byDrugtherapycanoften beenhanced by
nondrugmeasures.nondrugmeasures.
Biofeedback,emotionalsupport,weightBiofeedback,emotionalsupport,weightreduction,smokingcessation,sodiumreduction,smokingcessation,sodiumrestriction,etc.restriction,etc.
-
8/8/2019 3304-Module 1-
58/84
Minimizing AdverseEffectsMinimizing AdverseEffects
All drugshavethepotentialtoproduceAll drugshavethepotentialtoproduceundesired effects.undesired effects.
Always knowthefollowing:Always knowthefollowing:Themajoradverseeffectsthe drugcanThemajoradverseeffectsthe drugcanproduceproduce
ThetimewhenthesereactionsarelikelytoThetimewhenthesereactionsarelikelytooccuroccur
EarlysignsthatanadversereactionisEarlysignsthatanadversereactionisdevelopingdeveloping
Interventionsthatcanminimize discomfortandInterventionsthatcanminimize discomfortandharmharm
-
8/8/2019 3304-Module 1-
59/84
Minimizing Adverse InteractionsMinimizing Adverse Interactions
Takeathorough drughistory.Takeathorough drughistory.Advisethepatienttoavoid OTC drugsthatAdvisethepatienttoavoid OTC drugsthat
caninteractwiththeprescribedcaninteractwiththeprescribedmedication.medication.
MonitorforadverseinteractionsMonitorforadverseinteractionsknownknown totooccur.occur.
BealertforasBealertforas--yetyetunknownunknown interactions.interactions.
-
8/8/2019 3304-Module 1-
60/84
Making PRN DecisionsMaking PRN Decisions
PRNPRN pprorenata,meaningasneededrorenata,meaningasneededKnowthereasonfordruguse.Knowthereasonfordruguse.BeabletoassessthepatientsmedicationBeabletoassessthepatientsmedication
needs.needs.
-
8/8/2019 3304-Module 1-
61/84
ManagingToxicityManagingToxicity
EarlyidentificationmakesearlyEarlyidentificationmakesearlyinterventionpossible.interventionpossible.
Knowtheearlysignsoftoxicity.Knowtheearlysignsoftoxicity.KnowtheprocedurefortoxicityKnowtheprocedurefortoxicitymanagement.management.
-
8/8/2019 3304-Module 1-
62/84
-
8/8/2019 3304-Module 1-
63/84
OverviewofChapter3OverviewofChapter3
Landmark druglegislationNew drug developmentDrugnamesOver-the-counterdrugsSourcesofdruginformation
-
8/8/2019 3304-Module 1-
64/84
-
8/8/2019 3304-Module 1-
65/84
Food Drugand Cosmetic Act (1938) Targeted safetyand efficacy
Regulated manufacture, distribution,advertising,labeling
Made USP officialstandard forstrengthand purity
www.usp.org
-
8/8/2019 3304-Module 1-
66/84
Food Drugand Cosmetic Act (1938)
Designated FDA toenforce
RoleoftheFDA
http://www.fda.gov/
-
8/8/2019 3304-Module 1-
67/84
HarrisKefauverAmendment
Firstlawto demand that drugsactuallyoffersome benefit
-
8/8/2019 3304-Module 1-
68/84
Comprehensive Drug AbusePreventionand Control Act (1970)
Classified and regulated drugswithpotentialforabuse
Established drugabuseeducationandtreatmentprograms
Reallyfocusonthis ACT ***
-
8/8/2019 3304-Module 1-
69/84
Schedule 1: highabusepotential,noapproved medicaluse
Schedule2: highabusepotential,accepted medicaluse-codeine,anabolicsteroids
Schedule 3:lessabusepotential,accepted medicaluse
Schedule 4:someabusepotential,
accepted medicaluseSchedule5:lessabusepotentialthan
schedule 4,accepted medicaluse
Good ideato knowtheseschedules ***
-
8/8/2019 3304-Module 1-
70/84
1992 Rx Drug UserFee Act
Shortened review process
1997 FDA Modernization Act
Permitted drug companies to provide
information about non-FDA approveduses ( off-label uses)-you CANT market a drug
for a USE that is not approved by the FDA. You canshare the information, thats all.
-
8/8/2019 3304-Module 1-
71/84
New Drug DevelopmentNew Drug Development
Therandomized controlled trialTherandomized controlled trialControluseControluseRandomizationRandomization
BlindingBlinding
-
8/8/2019 3304-Module 1-
72/84
StagesofNew Drug DevelopmentStagesofNew Drug Development
PreclinicaltestingPreclinicaltestingClinicaltestingClinicaltesting
Phase 1: healthysubjects
Phase2: targetgroupPhase 3: largertargetgroup
Phase 4: FDA evaluationand
postmarketing surveillance***Knowthesesteps. *** usuallyan 8 yearprocess.***Knowthesesteps. *** usuallyan 8 yearprocess.
-
8/8/2019 3304-Module 1-
73/84
LimitationsoftheTesting ProcedureLimitationsoftheTesting Procedure
Limited informationforwomenandLimited informationforwomenandchildrenchildrenWomenWomen
ChildrenChildrenFailureto detectalladverseeffectsFailureto detectalladverseeffects
-
8/8/2019 3304-Module 1-
74/84
Exercising Discretion RegardingExercising Discretion RegardingNew DrugsNew Drugs
BeneitherthefirsttoadoptthenewnorBeneitherthefirsttoadoptthenewnorthelasttoabandontheold.thelasttoabandontheold.
Balancepotential benefitsagainstinherentBalancepotential benefitsagainstinherent
risks.risks.New drugsgenerallypresentgreaterrisksNew drugsgenerallypresentgreaterrisks
thantheold ones.thantheold ones.
-
8/8/2019 3304-Module 1-
75/84
-
8/8/2019 3304-Module 1-
76/84
Which Nameto UseWhich Nameto UseGenericorTrade?GenericorTrade?
ThelittleproblemswithgenericnamesThelittleproblemswithgenericnamesMorecomplicated thantradenamesMorecomplicated thantradenames
The bigproblemswithtradenamesThe bigproblemswithtradenames
Single drugcanhavemultipletradenames.Single drugcanhavemultipletradenames.U.S. drugsand drugsoutsidethe U.S.mayU.S. drugsand drugsoutsidethe U.S.may
have differentactiveingredients.have differentactiveingredients.ProductswiththesametradenamemayhaveProductswiththesametradenamemayhave
differentactiveingredients.differentactiveingredients.Monistatand KaopectateMonistatand Kaopectate
-
8/8/2019 3304-Module 1-
77/84
-
8/8/2019 3304-Module 1-
78/84
Which Nameto UseWhich Nameto UseGenericorTrade?GenericorTrade?
Genericproductsversus brandGenericproductsversus brand--namenameproductsproductsAregenericproductsand brandAregenericproductsand brand--nameproductsnameproducts
therapeuticallyequivalent?therapeuticallyequivalent?Would a difference between brandWould a difference between brand--nameandnameand
genericproducts justifytheuseoftradenames?genericproducts justifytheuseoftradenames?
-
8/8/2019 3304-Module 1-
79/84
OverOver--thethe--CounterDrugsCounterDrugs
Americansspend about $20 billionAmericansspend about $20 billionannuallyon OTC drugs.annuallyon OTC drugs.
OTC drugsaccountfor60%ofall dosesOTC drugsaccountfor60%ofall doses
administered.administered.40%ofAmericanstakeatleastone OTC40%ofAmericanstakeatleastone OTC
drugevery2 days.drugevery2 days.
FourtimesasmanyillnessesaretreatedFourtimesasmanyillnessesaretreatedbyaconsumerusingan OTC drugas byabyaconsumerusingan OTC drugas byaconsumervisitingaphysician.consumervisitingaphysician.
-
8/8/2019 3304-Module 1-
80/84
OverOver--thethe--CounterDrugsCounterDrugs
Withmostillnesses (60%to 95%),initialWithmostillnesses (60%to 95%),initialtherapyconsistsofselftherapyconsistsofself--care,includingcare,includingselfself--medicationwithan OTC drug.medicationwithan OTC drug.
TheaveragehomemedicinecabinetTheaveragehomemedicinecabinetcontains24 OTCpreparations.contains24 OTCpreparations.
-
8/8/2019 3304-Module 1-
81/84
SourcesofDrug InformationSourcesofDrug Information
PeoplePeopleCliniciansand pharmacistsCliniciansand pharmacistsPoisoncontrolcentersPoisoncontrolcenters
PharmaceuticalsalesrepresentativesPharmaceuticalsalesrepresentatives
-
8/8/2019 3304-Module 1-
82/84
Published InformationPublished Information
TextText--like bookslike booksGoodman & Gilmans,The PharmacologicalGoodman & Gilmans,The Pharmacological
BasisofTherapeuticsBasisofTherapeutics
Pharmacotherapy: A PathophysiologicPharmacotherapy: A PathophysiologicApproachApproachApplied Therapeutics:TheClinical UseofApplied Therapeutics:TheClinical Useof
DrugsDrugs
-
8/8/2019 3304-Module 1-
83/84
Published InformationPublished Information
NewslettersNewslettersTheMedical Letteron Drugsand TherapeuticsTheMedical Letteron Drugsand TherapeuticsPrescribers LetterPrescribers Letter
Reference booksReference booksPhysicians Desk ReferencePhysicians Desk ReferenceDrugFactsand ComparisonsDrugFactsand ComparisonsNursing drugreferencesNursing drugreferences
-
8/8/2019 3304-Module 1-
84/84